speb/financial-data huggingface dataset:
Financial ratios for 3901.T — annual report dated 2023-12-31
Total revenue: 34258728.6997101
Gross profit: 22526854.27419925
Operating income: 14081962.808456479
Net income: 9781524.42904617
Capital expenditures: 2003697.9424450258
Operating cash flow: 12621947.25305805
Depreciation & amortization: 193247.54295411156
Net tangible assets: 38527023.969454855
Owner earnings: 7971074.0295552565
Return on net tangible assets (%): 20.689565941752765
Capex to operating income (%): 14.228825694964684
Buffett classification: The Great
Stock price: 19.668033656225695
P/E ratio: 25.629848003579585
Shares outstanding: 12746520
Book value: 38917365.48115675
P/B ratio: 6.441828249683009
Market cap (USD): 250698984.35975394
Debt to equity: 0
Current ratio: 2.980280926759903
Quick ratio: 2.9604400556616213
Effective tax rate (%): 30.43443498007924
COGS to revenue (%): 34.24492055249595
SG&A to revenue (%): 0.7056863559324134
Free cash flow (dilution-adjusted): 10362235.734992575
Buyback yield (%): 0
Retained earnings: 33597631.3370572
Inventory turnover: 42.440121751585835
Receivables turnover: 20.63451882577903
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 36.120432151271075
FCF margin (%): 30.246994352362705
Revenue growth (%): 10.38330843667992
Rule of 40 score: 40.630302789042624
Financial ratios for 3901.T — annual report dated 2024-12-31
Total revenue: 35429670.679661125
Gross profit: 23052219.88661698
Operating income: 14116249.442639658
Net income: 10051321.74023823
Capital expenditures: 3724077.9667494744
Operating cash flow: 9814472.259379577
Depreciation & amortization: 332435.1869545831
Net tangible assets: 41593553.72953691
Owner earnings: 6659678.96044334
Return on net tangible assets (%): 16.01132474456995
Capex to operating income (%): 26.381497308346606
Buffett classification: The Good
Stock price: 13.321403686577565
P/E ratio: 16.893453707612597
Shares outstanding: 12746520
Book value: 42149417.160328686
P/B ratio: 4.028561957882848
Market cap (USD): 169801538.51903465
Debt to equity: 0
Current ratio: 3.13426435431181
Quick ratio: 3.0889863583986914
Effective tax rate (%): 29.15171912785096
COGS to revenue (%): 34.935269099606906
SG&A to revenue (%): 0.6592469324557757
Free cash flow (dilution-adjusted): 5773909.166188929
Buyback yield (%): 0.0004201500429523447
Retained earnings: 37288610.739537545
Inventory turnover: 20.192412008604293
Receivables turnover: 14.401499675053143
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 33.434905425102365
FCF margin (%): 16.29681861396335
Revenue growth (%): 3.417937630478777
Rule of 40 score: 19.71475624444213
Financial ratios for 3901.T — quarterly report dated 2025-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 15.980818072450209
Shares outstanding: 12746520
Market cap (USD): 203699817.17684802
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 3901.T — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 45708164.95986714
Buffett classification: The Gruesome
Stock price: 12.799820094104621
Shares outstanding: 12746520
Book value: 46631165.236645445
P/B ratio: 3.4988008984534518
Market cap (USD): 163153162.82590643
Debt to equity: 0
Current ratio: 2.004244543262923
Quick ratio: 1.9875063955565033
Buyback yield (%): 0
Retained earnings: 41315471.90700249
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 3901.T — quarterly report dated 2025-12-31
Capital expenditures: 0
Net tangible assets: 41103209.51345822
Buffett classification: The Gruesome
Stock price: 9.659637202743415
Shares outstanding: 12746520
Book value: 42034914.64740106
P/B ratio: 2.929154485749044
Market cap (USD): 123126758.797513
Debt to equity: 0
Current ratio: 1.9350008218851118
Quick ratio: 1.8995246576792217
Buyback yield (%): 0
Retained earnings: 43083492.104085416
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 3901.T — annual report dated 2025-12-31
Total revenue: 35613899.367048144
Gross profit: 23664215.842976794
Operating income: 13397992.455725338
Net income: 9716188.223259382
Capital expenditures: 232702.5126270699
Operating cash flow: 11567022.568889458
Depreciation & amortization: 633456.9400933444
Net tangible assets: 41103209.51345822
Owner earnings: 10116942.650725655
Return on net tangible assets (%): 24.613510162541235
Capex to operating income (%): 1.7368461237461705
Buffett classification: The Great
Stock price: 9.659637202743415
P/E ratio: 12.672331573688785
Shares outstanding: 12746520
Book value: 42034914.64740106
P/B ratio: 2.929154485749044
Market cap (USD): 123126758.797513
Debt to equity: 0
Current ratio: 1.9350008218851118
Quick ratio: 1.8995246576792217
Effective tax rate (%): 29.418064893632884
COGS to revenue (%): 33.55340848094471
SG&A to revenue (%): 0.6851070934246737
Free cash flow (dilution-adjusted): 11055616.648551883
Buyback yield (%): 5.191679777055581
Retained earnings: 43083492.104085416
Inventory turnover: 23.72642335766423
Receivables turnover: 19.089619295341688
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 31.806748632005345
FCF margin (%): 31.042982782113214
Revenue growth (%): 0.5199841936232795
Rule of 40 score: 31.562966975736494
Financial ratios for 5248.T — annual report dated 2023-01-31
Total revenue: 8242680.870631515
Gross profit: 3868922.440220724
Operating income: 1294351.6247700797
Net income: 572034.0282035562
Capital expenditures: 37047.82342121398
Operating cash flow: 490427.6517473943
Depreciation & amortization: 47340.588595953406
Net tangible assets: 4841454.629061925
Owner earnings: 582326.7933782956
Return on net tangible assets (%): 12.027930405104852
Capex to operating income (%): 2.862268854322713
Buffett classification: The Great
Stock price: 3.7030196198651137
P/E ratio: 109.54193260842185
Shares outstanding: 16921788
Book value: 5426816.370324954
P/B ratio: 11.546680169582725
Market cap (USD): 62661712.967198044
Debt to equity: 0.27981290540340154
Current ratio: 7.069184765016878
Quick ratio: 6.60627803381784
Effective tax rate (%): 36.441204772082806
Interest coverage ratio: 177.21615949632738
COGS to revenue (%): 53.06223587988899
SG&A to revenue (%): 7.980901994876826
Free cash flow (dilution-adjusted): 259641.32434089517
Buyback yield (%): 0
Retained earnings: -91270.69282648682
Inventory turnover: 9.501315263718702
Receivables turnover: 4.644285245448578
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 18.983191444879314
FCF margin (%): 3.1499621108223574
Rule of 40 score: 3.1499621108223574
Financial ratios for 5248.T — annual report dated 2024-01-31
Total revenue: 48378469.15925901
Gross profit: 12390669.742824184
Operating income: 5917296.600393567
Net income: 4060948.632693221
Capital expenditures: 1400705.7067245708
Operating cash flow: 6510816.312682364
Depreciation & amortization: 888097.98466445
Net tangible assets: 6134192.847933772
Owner earnings: 3548340.9106331
Return on net tangible assets (%): 57.84527807645167
Capex to operating income (%): 23.671379031962132
Buffett classification: The Great
Stock price: 5.281468412838434
P/E ratio: 22.007638336335475
Shares outstanding: 16921788
Book value: 26150844.812377006
P/B ratio: 3.417552643211335
Market cap (USD): 89371888.81074846
Debt to equity: 2.2176395033537895
Current ratio: 1.2309608430724588
Quick ratio: 0.9180373941914389
Effective tax rate (%): 30.5540824840125
Interest coverage ratio: 8.730359913900987
COGS to revenue (%): 74.38803512431036
SG&A to revenue (%): 1.3521919732493073
Free cash flow (dilution-adjusted): 4521686.910497387
Buyback yield (%): 0.0024903696997431407
Retained earnings: 935889.2583293751
Inventory turnover: 2.487335206194512
Receivables turnover: 3.395427351689204
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.780408727124076
FCF margin (%): 9.346486131283456
Revenue growth (%): 486.9263886174508
Rule of 40 score: 496.27287474873424
Financial ratios for 5248.T — annual report dated 2025-01-31
Total revenue: 90202985.07462686
Gross profit: 22280772.225827385
Operating income: 11283465.282284232
Net income: 5233354.9643088905
Capital expenditures: 1782147.95587281
Operating cash flow: 2689604.153147307
Depreciation & amortization: 1442887.7352368592
Net tangible assets: 7615353.666450357
Owner earnings: 4894094.743672939
Return on net tangible assets (%): 64.26615175121812
Capex to operating income (%): 15.794331894395041
Buffett classification: The Great
Stock price: 4.542504866969501
P/E ratio: 14.687959229224019
Shares outstanding: 16921788
Book value: 28535438.027255043
P/B ratio: 2.6937488842613124
Market cap (USD): 76867304.3478261
Debt to equity: 1.6902522928216805
Current ratio: 1.1604733113737005
Quick ratio: 0.8624396055880633
Effective tax rate (%): 52.02344394168522
Interest coverage ratio: 15.737435173368812
COGS to revenue (%): 75.29928893518692
SG&A to revenue (%): 2.672147611415022
Free cash flow (dilution-adjusted): -1961051.26541207
Buyback yield (%): 0
Retained earnings: 2620830.629461389
Inventory turnover: 3.939313831240633
Receivables turnover: 4.291578148218243
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 17.327748162669657
FCF margin (%): -2.1740425372726304
Revenue growth (%): 86.45274776612726
Rule of 40 score: 84.27870522885463
Financial ratios for 5248.T — quarterly report dated 2025-04-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.820801124385102
Shares outstanding: 16921788
Market cap (USD): 81576574.61700632
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 5248.T — quarterly report dated 2025-07-31
Capital expenditures: 0
Net tangible assets: 8602050.52603364
Buffett classification: The Gruesome
Stock price: 5.246934262547746
Shares outstanding: 16921788
Book value: 31886222.609394893
P/B ratio: 2.784510110476652
Market cap (USD): 88787509.2407693
Debt to equity: 1.901787603808943
Current ratio: 1.155849230246053
Quick ratio: 0.8427621883832104
Buyback yield (%): 0
Retained earnings: 3662983.3143469812
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 5248.T — quarterly report dated 2026-01-31
Capital expenditures: 0
Net tangible assets: 8553930.530164534
Buffett classification: The Gruesome
Stock price: 3.5126664925568036
Shares outstanding: 16921788
Book value: 34642863.67197701
P/B ratio: 1.7158107443014867
Market cap (USD): 59440597.70174981
Debt to equity: 1.8603241937608714
Current ratio: 1.124213072481179
Quick ratio: 0.9378481896543429
Buyback yield (%): 0
Retained earnings: 4379433.272394882
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 5248.T — annual report dated 2026-01-31
Total revenue: 66264605.64115957
Gross profit: 23071617.915904935
Operating income: 12224001.04465918
Net income: 7204478.976234004
Capital expenditures: 6402337.424915122
Operating cash flow: -4478075.215460956
Depreciation & amortization: 1668542.7004439803
Net tangible assets: 8553930.530164534
Owner earnings: 2470684.2517628614
Return on net tangible assets (%): 28.88361371477421
Capex to operating income (%): 52.37513807079053
Buffett classification: The Good
Stock price: 3.5126664925568036
P/E ratio: 8.250506094588006
Shares outstanding: 16921788
Book value: 34642863.67197701
P/B ratio: 1.7158107443014867
Market cap (USD): 59440597.70174981
Debt to equity: 1.8603241937608714
Current ratio: 1.124213072481179
Quick ratio: 0.9378481896543429
Effective tax rate (%): 34.87620767600937
Interest coverage ratio: 11.186563418656343
COGS to revenue (%): 65.182582433277
SG&A to revenue (%): 1.5218413242491664
Free cash flow (dilution-adjusted): -14063952.729172109
Buyback yield (%): 0
Retained earnings: 4379433.272394882
Inventory turnover: 3.0495356622287293
Receivables turnover: 2.9910737152330076
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 16.10680401206728
FCF margin (%): -21.22392881251289
Revenue growth (%): -26.538345059936276
Rule of 40 score: -47.76227387244917
Financial ratios for 5631.T — annual report dated 2022-03-31
Total revenue: 1752089821.3407638
Gross profit: 391870185.21553844
Operating income: 126741517.78396985
Net income: 115743320.76708737
Capital expenditures: 56031798.06589084
Operating cash flow: 182961809.53941977
Depreciation & amortization: 52024258.31830847
Net tangible assets: 1208711686.6087527
Owner earnings: 111735781.019505
Return on net tangible assets (%): 9.24420457396245
Capex to operating income (%): 44.20950533462658
Buffett classification: The Good
Stock price: 29.275856416980822
P/E ratio: 18.618945633007147
Shares outstanding: 73610779
Book value: 1238165874.446812
P/B ratio: 1.740492644177362
Market cap (USD): 2155018596.746107
Debt to equity: 0.3868189911372046
Current ratio: 1.875495673781554
Quick ratio: 1.3206163094343555
Effective tax rate (%): 28.44041345764086
Interest coverage ratio: 55.0355871886121
COGS to revenue (%): 77.63412694700406
R&D to revenue (%): 1.939286215445063
SG&A to revenue (%): 8.43631601103887
Free cash flow (dilution-adjusted): 110801507.94951648
Buyback yield (%): 0
Retained earnings: 1014505818.718243
Inventory turnover: 2.225359666411917
Receivables turnover: 3.8286174785100284
Capitalized R&D asset: 33978036.387477465
ROCI (R&D-adjusted, %): 8.702771863154176
FCF margin (%): 6.323962767201459
Rule of 40 score: 6.323962767201459
Financial ratios for 5631.T — annual report dated 2023-03-31
Total revenue: 1792199699.6996999
Gross profit: 370720720.72072077
Operating income: 103986486.4864865
Net income: 89894894.8948949
Capital expenditures: 1584084.0840840843
Operating cash flow: -7402402.402402403
Depreciation & amortization: 50570570.57057057
Net tangible assets: 1182897897.897898
Owner earnings: 138881381.3813814
Return on net tangible assets (%): 11.740775059976391
Capex to operating income (%): 1.5233557143888528
Buffett classification: The Great
Stock price: 17.788063063063063
P/E ratio: 14.565823571006346
Shares outstanding: 73610779
Book value: 1205968468.4684687
P/B ratio: 1.085760708682603
Market cap (USD): 1309393178.9731982
Debt to equity: 0.27029601269959846
Current ratio: 1.9201816435245829
Quick ratio: 1.2597444182458593
Effective tax rate (%): 35.5221946214494
Interest coverage ratio: 65.95714285714286
COGS to revenue (%): 79.31434603574884
R&D to revenue (%): 1.767335089916681
SG&A to revenue (%): 8.791853251284973
Free cash flow (dilution-adjusted): -55037537.537537545
Buyback yield (%): 0
Retained earnings: 984181681.6816818
Inventory turnover: 2.086345204513399
Receivables turnover: 3.4838083563183164
Capitalized R&D asset: 54439458.55378408
ROCI (R&D-adjusted, %): 6.9455668603770295
Rosenberg metric: -0.6224451658605047
FCF margin (%): -3.0709489320168735
Revenue growth (%): 2.2892592531724496
Rule of 40 score: -0.7816896788444239
Financial ratios for 5631.T — annual report dated 2024-03-31
Total revenue: 1667333597.4643424
Gross profit: 375151875.3301638
Operating income: 118977812.99524565
Net income: 95410723.7189646
Capital expenditures: 55791072.37189646
Operating cash flow: 143337295.29846805
Depreciation & amortization: 52192287.37453777
Net tangible assets: 1157719228.7374537
Owner earnings: 91811938.72160591
Return on net tangible assets (%): 7.93041494367603
Capex to operating income (%): 46.89199689199689
Buffett classification: The Good
Stock price: 21.827918647649234
P/E ratio: 16.84056081929407
Shares outstanding: 73610779
Book value: 1179424194.4004228
P/B ratio: 1.362334351991915
Market cap (USD): 1606770095.6020865
Debt to equity: 0.24429489619958342
Current ratio: 1.9054332946514811
Quick ratio: 1.2274145466927018
Effective tax rate (%): 24.748711004635176
Interest coverage ratio: 84.99056603773585
COGS to revenue (%): 77.49989108954024
R&D to revenue (%): 1.8388045987936683
SG&A to revenue (%): 9.042736464410043
Free cash flow (dilution-adjusted): 75647120.97200212
Buyback yield (%): 0
Retained earnings: 931741944.0042261
Inventory turnover: 2.0055548153690057
Receivables turnover: 4.149769092970894
Capitalized R&D asset: 63093455.57197049
ROCI (R&D-adjusted, %): 7.658180404018275
Rosenberg metric: 0.139898031281775
FCF margin (%): 4.537011734606992
Revenue growth (%): -6.967198033582978
Rule of 40 score: -2.430186298975986
Financial ratios for 5631.T — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 1255098753.3267965
Buffett classification: The Gruesome
Stock price: 34.53887099033478
Shares outstanding: 73610779
Book value: 1280025213.6153522
P/B ratio: 1.9862368118500566
Market cap (USD): 2542433199.3790445
Debt to equity: 0.22976329871636336
Current ratio: 1.8369525790975725
Quick ratio: 0.986921439668211
Buyback yield (%): 0
Retained earnings: 1014876033.0578512
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 5631.T — annual report dated 2025-03-31
Total revenue: 1661248496.1903489
Gross profit: 407652720.2245689
Operating income: 152566501.80457157
Net income: 121327362.65205187
Capital expenditures: 101410239.27282448
Operating cash flow: -30523994.118433364
Depreciation & amortization: 53301697.63400615
Net tangible assets: 1276426948.268948
Owner earnings: 73218821.01323353
Return on net tangible assets (%): 5.736232779520261
Capex to operating income (%): 66.46953169492268
Buffett classification: The Good
Stock price: 34.64035556743751
P/E ratio: 21.016722876180797
Shares outstanding: 73610779
Book value: 1303970057.478947
P/B ratio: 1.955492416049769
Market cap (USD): 2549903558.156062
Debt to equity: 0.22310097385955915
Current ratio: 1.7633040438566665
Quick ratio: 0.9846692555939321
Effective tax rate (%): 22.109237568112583
Interest coverage ratio: 83.31021897810218
COGS to revenue (%): 75.46066077664591
R&D to revenue (%): 1.8016060766990134
SG&A to revenue (%): 8.783936014419286
Free cash flow (dilution-adjusted): -136332041.17096645
Buyback yield (%): 0
Retained earnings: 1029668493.5169095
Inventory turnover: 1.4369483942142682
Receivables turnover: 4.115301831186463
Capitalized R&D asset: 60923165.93507595
ROCI (R&D-adjusted, %): 9.475600629511785
Rosenberg metric: 1.060074940945232
FCF margin (%): -8.206601329277909
Revenue growth (%): -0.3649600345874172
Rule of 40 score: -8.571561363865326
Financial ratios for 5631.T — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: 1276426948.268948
Buffett classification: The Gruesome
Stock price: 34.64035556743751
Shares outstanding: 73610779
Book value: 1303970057.478947
P/B ratio: 1.955492416049769
Market cap (USD): 2549903558.156062
Debt to equity: 0.22310097385955915
Current ratio: 1.7633040438566665
Quick ratio: 0.9846692555939321
Buyback yield (%): 0
Retained earnings: 1029668493.5169095
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 5631.T — quarterly report dated 2025-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 56.65035981179075
Shares outstanding: 73610779
Market cap (USD): 4170077116.3762107
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 5631.T — quarterly report dated 2025-09-30
Capital expenditures: 0
Net tangible assets: 1336211305.5181696
Buffett classification: The Gruesome
Stock price: 60.24919246298789
Shares outstanding: 73610779
Book value: 1365592193.8088827
P/B ratio: 3.2476679432030737
Market cap (USD): 4434989991.321467
Debt to equity: 0.28147067664726727
Current ratio: 2.175132246778997
Quick ratio: 1.1626233473937242
Buyback yield (%): 0
Retained earnings: 1080874831.7631226
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 5ZM.DE — annual report dated 2022-01-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 150.2222222222222
Shares outstanding: 264645644
Market cap (USD): 39755656743.11111
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 5ZM.DE — annual report dated 2023-01-31
Total revenue: 4392960000
Gross profit: 3292509000
Operating income: 245429000
Net income: 103711000
Capital expenditures: 103826000
Operating cash flow: 1290262000
Depreciation & amortization: 82321000
Net tangible assets: 6027307000
Owner earnings: 82206000
Return on net tangible assets (%): 1.3638926970204106
Capex to operating income (%): 42.30388421906132
Buffett classification: The Good
Stock price: 74.34782608695653
P/E ratio: 189.717853600704
Shares outstanding: 264645644
Book value: 6206607000
P/B ratio: 3.170142448971332
Market cap (USD): 19675828314.78261
Debt to equity: 0.015544241805546895
Current ratio: 3.6559594718642803
Quick ratio: 3.6559594718642803
Effective tax rate (%): 58.395112245061696
COGS to revenue (%): 25.050330528846153
R&D to revenue (%): 17.620442708333332
SG&A to revenue (%): 51.74235595134032
Free cash flow (dilution-adjusted): -110584000
Buyback yield (%): 5.082393401698313
Retained earnings: 2151818000
Receivables turnover: 7.881105984169471
Capitalized R&D asset: 774059000
ROCI (R&D-adjusted, %): 10.62986611721305
FCF margin (%): -2.5173004079254078
Rule of 40 score: -2.5173004079254078
Financial ratios for 5ZM.DE — annual report dated 2024-01-31
Total revenue: 4527224000
Gross profit: 3449423000
Operating income: 525279000
Net income: 637462000
Capital expenditures: 126953000
Operating cash flow: 1598836000
Depreciation & amortization: 104451000
Net tangible assets: 7639937000
Owner earnings: 614960000
Return on net tangible assets (%): 8.049281034647276
Capex to operating income (%): 24.168679882500538
Buffett classification: The Great
Stock price: 65.57608695652173
P/E ratio: 27.224251427706584
Shares outstanding: 264645644
Book value: 8019406000
P/B ratio: 2.1640537670257243
Market cap (USD): 17354425763.608696
Debt to equity: 0.009097057812012511
Current ratio: 4.497944315784874
Quick ratio: 4.497944315784874
Effective tax rate (%): 23.410692144292046
COGS to revenue (%): 23.80710563471125
R&D to revenue (%): 17.741269263460346
SG&A to revenue (%): 46.84895202888127
Free cash flow (dilution-adjusted): 414722000
Buyback yield (%): 0
Retained earnings: 2789280000
Receivables turnover: 8.445084483974346
Capitalized R&D asset: 1321806530
ROCI (R&D-adjusted, %): 8.459083539635442
Rosenberg metric: 0.20271581365244767
FCF margin (%): 9.16062470069959
Revenue growth (%): 3.056344696969697
Rule of 40 score: 12.216969397669287
Financial ratios for 5ZM.DE — quarterly report dated 2024-10-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 75.17391304347825
Shares outstanding: 264645644
Market cap (USD): 19894448629.3913
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 5ZM.DE — annual report dated 2025-01-31
Total revenue: 4665433000
Gross profit: 3535806000
Operating income: 813295000
Net income: 1010238000
Capital expenditures: 136560000
Operating cash flow: 1945308000
Depreciation & amortization: 122632000
Net tangible assets: 8569140000
Owner earnings: 996310000
Return on net tangible assets (%): 11.62672100117398
Capex to operating income (%): 16.790955311418365
Buffett classification: The Great
Stock price: 88.33333333333333
P/E ratio: 23.140123304277473
Shares outstanding: 264645644
Book value: 8935084000
P/B ratio: 2.61631920714642
Market cap (USD): 23377031886.666664
Debt to equity: 0.007211124148357195
Current ratio: 4.558399280405444
Quick ratio: 4.558399280405444
Effective tax rate (%): 23.209920461179216
COGS to revenue (%): 24.212693655658544
R&D to revenue (%): 18.270865748152424
SG&A to revenue (%): 40.08408222773749
Free cash flow (dilution-adjusted): 877439000
Buyback yield (%): 4.67928522878007
Retained earnings: 3799518000
Receivables turnover: 9.420777904318818
Capitalized R&D asset: 1645989760
ROCI (R&D-adjusted, %): 7.975153184336427
Rosenberg metric: 0.10755029650629305
FCF margin (%): 18.807236112918137
Revenue growth (%): 3.0528420948466435
Rule of 40 score: 21.86007820776478
Financial ratios for 5ZM.DE — quarterly report dated 2025-01-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 88.33333333333333
Shares outstanding: 264645644
Market cap (USD): 23377031886.666664
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 5ZM.DE — quarterly report dated 2025-04-30
Total revenue: 1174715000
Gross profit: 896313000
Operating income: 241592000
Net income: 254603000
Capital expenditures: 25910000
Operating cash flow: 489261000
Depreciation & amortization: 35316000
Net tangible assets: 8539713000
Owner earnings: 264009000
Return on net tangible assets (%): 3.0915441771872194
Capex to operating income (%): 10.724692870624855
Buffett classification: The Great
Stock price: 76.92045454545455
P/E ratio: 19.98863252785174
Shares outstanding: 264645644
Book value: 8902368000
P/B ratio: 2.2866571265032567
Market cap (USD): 20356663229.954544
Debt to equity: 0.0069056907106064365
Current ratio: 4.567777131855466
Quick ratio: 4.567777131855466
Effective tax rate (%): 19.3694678004212
COGS to revenue (%): 23.699535632046924
R&D to revenue (%): 17.486454161222085
SG&A to revenue (%): 38.24800057886381
Free cash flow (dilution-adjusted): 261782000
Buyback yield (%): 2.0534848726331925
Retained earnings: 4054121000
Receivables turnover: 2.4614660905787837
Capitalized R&D asset: 205416000
ROCI (R&D-adjusted, %): 4.087888699914762
FCF margin (%): 22.28472437995599
Rule of 40 score: 22.28472437995599
Financial ratios for 5ZM.DE — quarterly report dated 2025-07-31
Total revenue: 1217227000
Gross profit: 944062000
Operating income: 321735000
Net income: 358592000
Capital expenditures: 7966000
Operating cash flow: 515940000
Depreciation & amortization: 32163000
Net tangible assets: 8590176000
Owner earnings: 382789000
Return on net tangible assets (%): 4.456125229564563
Capex to operating income (%): 2.4759507047725613
Buffett classification: The Great
Stock price: 78.2183908045977
P/E ratio: 33.757868878784784
Shares outstanding: 264645644
Book value: 8950077000
P/B ratio: 2.3128467394332404
Market cap (USD): 20700156407.12644
Debt to equity: 0.006062294212664316
Current ratio: 4.4479616774829545
Quick ratio: 4.4479616774829545
Effective tax rate (%): 19.98607646342171
COGS to revenue (%): 22.44158238356527
R&D to revenue (%): 16.96043548163161
SG&A to revenue (%): 34.166182643007424
Free cash flow (dilution-adjusted): 318775000
Buyback yield (%): 2.247630360125318
Retained earnings: 4412713000
Receivables turnover: 2.3553199599844428
Capitalized R&D asset: 344075720
ROCI (R&D-adjusted, %): 4.14062859578219
Rosenberg metric: 0.23245024730303385
FCF margin (%): 26.188623814621266
Revenue growth (%): 3.618920333868215
Rule of 40 score: 29.80754414848948
Financial ratios for 5ZM.DE — quarterly report dated 2025-10-31
Total revenue: 1229835000
Gross profit: 958065000
Operating income: 310414000
Net income: 612873000
Capital expenditures: 15009000
Operating cash flow: 629326000
Depreciation & amortization: 32391000
Net tangible assets: 8930215000
Owner earnings: 630255000
Return on net tangible assets (%): 7.057556844935984
Capex to operating income (%): 4.835155630867165
Buffett classification: The Great
Stock price: 79.12790697674419
P/E ratio: 17.0796855478102
Shares outstanding: 264645644
Book value: 9286840000
P/B ratio: 2.254895734203729
Market cap (USD): 20940855900.23256
Debt to equity: 0.005218675028319643
Current ratio: 4.447721089320683
Quick ratio: 4.447721089320683
Effective tax rate (%): 22.88082807669222
COGS to revenue (%): 22.098086328653842
R&D to revenue (%): 17.083348579280962
SG&A to revenue (%): 35.57826862953161
Free cash flow (dilution-adjusted): 429035000
Buyback yield (%): 1.975592602188746
Retained earnings: 5025586000
Receivables turnover: 2.9443514734505967
Capitalized R&D asset: 416203770
ROCI (R&D-adjusted, %): 3.180381633549377
Rosenberg metric: 0.06782854679409243
FCF margin (%): 34.885574081075916
Revenue growth (%): 1.035796938451086
Rule of 40 score: 35.921371019527
Financial ratios for 5ZM.DE — annual report dated 2026-01-31
Total revenue: 4868769000
Gross profit: 3749733000
Operating income: 1123633000
Net income: 1900148000
Capital expenditures: 64961000
Operating cash flow: 1989048000
Depreciation & amortization: 132831000
Net tangible assets: 9336630000
Owner earnings: 1968018000
Return on net tangible assets (%): 21.078461928982943
Capex to operating income (%): 5.7813360768151165
Buffett classification: The Great
Stock price: 91.55952380952381
P/E ratio: 12.752074650450787
Shares outstanding: 264645644
Book value: 9808258000
P/B ratio: 2.4704518521948304
Market cap (USD): 24230829142.904762
Debt to equity: 0.0059618129947234255
Current ratio: 4.330733447046054
Quick ratio: 4.330733447046054
Effective tax rate (%): 21.555556014259263
COGS to revenue (%): 22.983961654373005
R&D to revenue (%): 17.35294896923637
SG&A to revenue (%): 36.58470960524108
Free cash flow (dilution-adjusted): 1162811000
Buyback yield (%): 6.6885494938771775
Retained earnings: 5699666000
Receivables turnover: 9.789638455862098
Capitalized R&D asset: 1681044760
ROCI (R&D-adjusted, %): 9.749091822931168
Rosenberg metric: 0.25096578544488307
FCF margin (%): 23.883059557765012
Revenue growth (%): 4.358352161524985
Rule of 40 score: 28.24141171929
Financial ratios for 5ZM.DE — quarterly report dated 2026-01-31
Total revenue: 1246992000
Gross profit: 951293000
Operating income: 249892000
Net income: 674080000
Capital expenditures: 16076000
Operating cash flow: 354521000
Depreciation & amortization: 32961000
Net tangible assets: 9336630000
Owner earnings: 690965000
Return on net tangible assets (%): 7.4005824371320275
Capex to operating income (%): 6.433179133385622
Buffett classification: The Great
Stock price: 91.55952380952381
P/E ratio: 12.752074650450787
Shares outstanding: 264645644
Book value: 9808258000
P/B ratio: 2.4704518521948304
Market cap (USD): 24230829142.904762
Debt to equity: 0.0059618129947234255
Current ratio: 4.330733447046054
Quick ratio: 4.330733447046054
Effective tax rate (%): 21.949773576997135
COGS to revenue (%): 23.712982922103752
R&D to revenue (%): 17.876217329381426
SG&A to revenue (%): 38.37121649537447
Free cash flow (dilution-adjusted): 153219000
Buyback yield (%): 1.335905585776398
Retained earnings: 5699666000
Receivables turnover: 2.5073279996139455
Capitalized R&D asset: 431807500
ROCI (R&D-adjusted, %): 2.498346608812528
Rosenberg metric: -0.03223273059586762
FCF margin (%): 12.287087647715463
Revenue growth (%): 1.3950651916720536
Rule of 40 score: 13.682152839387516
Financial ratios for 6614.T — annual report dated 2022-03-31
Total revenue: 43919488.60842485
Gross profit: 11698033.10932634
Operating income: 3250295.0336010493
Net income: 2683838.71496476
Capital expenditures: 1003605.9662350435
Operating cash flow: 200696.60711358793
Depreciation & amortization: 911080.1507949517
Net tangible assets: 12694173.086379282
Owner earnings: 2591312.899524668
Return on net tangible assets (%): 20.41340449584007
Capex to operating income (%): 30.87738054114841
Buffett classification: The Good
Stock price: 16.034994263235536
P/E ratio: 26.235418589632406
Shares outstanding: 4391123
Book value: 13445812.161940668
P/B ratio: 5.23669610032682
Market cap (USD): 70411632.11416161
Debt to equity: 0.25128942168325147
Current ratio: 1.8954997015831125
Quick ratio: 1.3789822910688194
Effective tax rate (%): 20.88469064817723
Interest coverage ratio: 98.80443447932237
COGS to revenue (%): 73.36482395406952
Free cash flow (dilution-adjusted): -1035953.1224389445
Buyback yield (%): 0.0007565505037376611
Retained earnings: 7129208.326503852
Inventory turnover: 5.447265603351769
Receivables turnover: 4.804466789548802
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 14.704730788425188
FCF margin (%): -2.3587549747567484
Rule of 40 score: -2.3587549747567484
Financial ratios for 6614.T — annual report dated 2023-03-31
Total revenue: 48621764.26426427
Gross profit: 13478813.813813815
Operating income: 4934624.624624625
Net income: 3581403.9039039044
Capital expenditures: 1152702.7027027027
Operating cash flow: 452665.1651651652
Depreciation & amortization: 780773.2732732734
Net tangible assets: 14077379.87987988
Owner earnings: 3209474.474474475
Return on net tangible assets (%): 22.798805614826247
Capex to operating income (%): 23.359481022133238
Buffett classification: The Great
Stock price: 27.106606606606608
P/E ratio: 33.235135415046436
Shares outstanding: 4391123
Book value: 15622515.015015014
P/B ratio: 7.619032121769277
Market cap (USD): 119028443.72222222
Debt to equity: 0.2914346978426359
Current ratio: 1.9116556373881457
Quick ratio: 1.2925779588251998
Effective tax rate (%): 22.23299957941137
Interest coverage ratio: 136.00082764328573
COGS to revenue (%): 72.27821424154305
Free cash flow (dilution-adjusted): -1184354.3543543546
Buyback yield (%): 0.0007127274135652372
Retained earnings: 9780780.780780781
Inventory turnover: 3.9908673774743426
Receivables turnover: 4.162428989095218
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 20.00316499996957
FCF margin (%): -2.4358522819477866
Revenue growth (%): 10.70658107557611
Rule of 40 score: 8.270728793628324
Financial ratios for 6614.T — annual report dated 2024-03-31
Total revenue: 46829906.233491816
Gross profit: 12400878.23560486
Operating income: 3992029.846804015
Net income: 3364837.559429477
Capital expenditures: 1142208.1352350765
Operating cash flow: 3270027.733755943
Depreciation & amortization: 666422.3454833598
Net tangible assets: 15154536.45007924
Owner earnings: 2889051.76967776
Return on net tangible assets (%): 19.063940221428904
Capex to operating income (%): 28.612214313716084
Buffett classification: The Good
Stock price: 15.870311674590598
P/E ratio: 20.710803829495795
Shares outstanding: 4391123
Book value: 16828625.19809826
P/B ratio: 4.141068553795976
Market cap (USD): 69688490.6114633
Debt to equity: 0.2297844990459194
Current ratio: 1.9246432035402314
Quick ratio: 1.3164568198299496
Effective tax rate (%): 20.297711869841383
Interest coverage ratio: 155.25243965074475
COGS to revenue (%): 73.51930457206166
Free cash flow (dilution-adjusted): 1251815.9006867406
Buyback yield (%): 0.3160430652262152
Retained earnings: 11495529.582673006
Inventory turnover: 4.299369186621809
Receivables turnover: 4.380922759122546
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 16.07630108897087
FCF margin (%): 2.6731121229353794
Revenue growth (%): -3.6853003133196136
Rule of 40 score: -1.0121881903842342
Financial ratios for 6614.T — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 15425857.963300182
Buffett classification: The Gruesome
Stock price: 9.973525703880094
Shares outstanding: 4391123
Book value: 17429668.020731196
P/B ratio: 2.5126685176853885
Market cap (USD): 43794978.10939907
Debt to equity: 0.39048054173256697
Current ratio: 2.045935512255801
Quick ratio: 1.3165587259613885
Buyback yield (%): 0
Retained earnings: 11853466.87211094
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 6614.T — annual report dated 2025-03-31
Total revenue: 43550401.01590696
Gross profit: 8661228.445395
Operating income: 376293.27629995986
Net income: -97473.59978612485
Capital expenditures: 641451.6775832108
Operating cash flow: 1318841.064028873
Depreciation & amortization: 987234.3269616361
Net tangible assets: 14752526.400213875
Owner earnings: 248309.04959230043
Capex to operating income (%): 170.4658887053516
Buffett classification: The Gruesome
Stock price: 6.948001604063627
Shares outstanding: 4391123
Book value: 16515338.858441383
P/B ratio: 1.8473450595926793
Market cap (USD): 30509529.647640686
Debt to equity: 0.2772464867818011
Current ratio: 2.261273380350114
Quick ratio: 1.5896228159319816
Interest coverage ratio: 8.960846729269457
COGS to revenue (%): 80.11217292297388
Free cash flow (dilution-adjusted): -35804.03689346344
Buyback yield (%): 0
Retained earnings: 11094178.585750569
Inventory turnover: 4.955043018673065
Receivables turnover: 5.043293615012209
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.4646397245381588
FCF margin (%): -0.08221287533124177
Revenue growth (%): -7.0030147001221605
Rule of 40 score: -7.085227575453402
Financial ratios for 6614.T — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: 14752526.400213875
Buffett classification: The Gruesome
Stock price: 6.948001604063627
Shares outstanding: 4391123
Book value: 16515338.858441383
P/B ratio: 1.8473450595926793
Market cap (USD): 30509529.647640686
Debt to equity: 0.2772464867818011
Current ratio: 2.261273380350114
Quick ratio: 1.5896228159319816
Buyback yield (%): 0
Retained earnings: 11094178.585750569
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 6614.T — quarterly report dated 2025-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 5.9773041793523385
Shares outstanding: 4391123
Market cap (USD): 26247077.859950177
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 6614.T — quarterly report dated 2025-09-30
Capital expenditures: 0
Net tangible assets: 14044878.869448183
Buffett classification: The Gruesome
Stock price: 5.304576043068641
Shares outstanding: 4391123
Book value: 15676904.441453572
P/B ratio: 1.4858192160931456
Market cap (USD): 23293045.8679677
Debt to equity: 0.4389535832087046
Current ratio: 1.9720869304310336
Quick ratio: 1.4204259546354
Buyback yield (%): 0
Retained earnings: 10384475.100942127
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 6897.T — annual report dated 2022-02-28
Total revenue: 111350795.98546462
Gross profit: 39180420.4879737
Operating income: 6223706.523620004
Net income: 3628015.2275480186
Capital expenditures: 3573914.1720020766
Operating cash flow: 13130351.271846341
Depreciation & amortization: 2976310.780411836
Net tangible assets: 73722097.24865894
Owner earnings: 3030411.835957778
Return on net tangible assets (%): 4.1105882076800295
Capex to operating income (%): 57.424207880600996
Buffett classification: The Good
Stock price: 5.139210936148123
P/E ratio: 15.10812600339593
Shares outstanding: 10665550
Book value: 75288458.2107631
P/B ratio: 0.7280333865596244
Market cap (USD): 54812511.20003461
Debt to equity: 0.16948714294907746
Current ratio: 2.971971068613028
Quick ratio: 1.6266851495605594
Effective tax rate (%): 27.15224079733019
Interest coverage ratio: 45.65763249761981
COGS to revenue (%): 64.81351678428585
R&D to revenue (%): 3.5992284337321316
SG&A to revenue (%): 7.0136150754569275
Free cash flow (dilution-adjusted): 8544782.834400415
Buyback yield (%): 0
Retained earnings: 27960053.6424987
Inventory turnover: 2.9235525850013495
Receivables turnover: 7.661714007445062
Capitalized R&D asset: 4007769.510295899
ROCI (R&D-adjusted, %): 10.863969084833908
FCF margin (%): 7.673751012535038
Rule of 40 score: 7.673751012535038
Financial ratios for 6897.T — annual report dated 2023-02-28
Total revenue: 79504350.05868545
Gross profit: 25236524.354460094
Operating income: 314964.7887323944
Net income: 421742.9577464789
Capital expenditures: 2554386.737089202
Operating cash flow: 871933.6854460094
Depreciation & amortization: 3045723.298122066
Net tangible assets: 56905443.07511737
Owner earnings: 913079.518779343
Return on net tangible assets (%): 1.6045556794523907
Capex to operating income (%): 811.007080305571
Buffett classification: The Gruesome
Stock price: 3.5842136150234745
P/E ratio: 90.64196288179225
Shares outstanding: 10665550
Book value: 59702112.67605634
P/B ratio: 0.640305808424848
Market cap (USD): 38227609.521713614
Debt to equity: 0.18557251672033687
Current ratio: 3.230203316712897
Quick ratio: 1.86773830896993
Effective tax rate (%): 50.95752757423504
Interest coverage ratio: 2.5985595836107245
COGS to revenue (%): 68.25768107552356
R&D to revenue (%): 3.5467044619627934
SG&A to revenue (%): 9.424505350740304
Free cash flow (dilution-adjusted): -3017502.9342723005
Buyback yield (%): 0
Retained earnings: 21466211.854460094
Inventory turnover: 2.8875047277499113
Receivables turnover: 5.031451349708945
Capitalized R&D asset: 5504989.902884169
ROCI (R&D-adjusted, %): 1.1707453120154558
Rosenberg metric: -3.4792160820855456
FCF margin (%): -3.79539349990907
Revenue growth (%): -28.600106218312348
Rule of 40 score: -32.395499718221416
Financial ratios for 6897.T — annual report dated 2024-02-29
Total revenue: 68386426.39054826
Gross profit: 22467217.57599894
Operating income: 756564.4497544139
Net income: 717907.8720297358
Capital expenditures: 1017416.6998539759
Operating cash flow: 3076543.2098765434
Depreciation & amortization: 2807646.356033453
Net tangible assets: 51078700.38497279
Owner earnings: 2508137.5282092127
Return on net tangible assets (%): 4.910339357316733
Capex to operating income (%): 134.47852330151602
Buffett classification: The Gruesome
Stock price: 3.1585689632284617
P/E ratio: 46.92506729382397
Shares outstanding: 10665550
Book value: 54358091.065976374
P/B ratio: 0.6197398500413329
Market cap (USD): 33687875.20576132
Debt to equity: 0.18272440989109343
Current ratio: 2.874602074616061
Quick ratio: 1.5023482706537465
Effective tax rate (%): 9.946881140307056
Interest coverage ratio: 13.880175353141743
COGS to revenue (%): 67.14666140740762
R&D to revenue (%): 4.082198957808713
SG&A to revenue (%): 8.937272174129356
Free cash flow (dilution-adjusted): 906192.7518916767
Buyback yield (%): 0
Retained earnings: 19202966.945440065
Inventory turnover: 2.2894515988332653
Receivables turnover: 5.304676957390513
Capitalized R&D asset: 6003489.4255557945
ROCI (R&D-adjusted, %): 0.5193771185061313
Rosenberg metric: -0.9820987896237042
FCF margin (%): 1.3251061646597786
Revenue growth (%): -13.984044470435384
Rule of 40 score: -12.658938305775605
Financial ratios for 6897.T — annual report dated 2025-02-28
Total revenue: 67040317.31217919
Gross profit: 19869722.018532097
Operating income: 32217.852143190456
Net income: -678608.0927938138
Capital expenditures: 1341563.8957402841
Operating cash flow: -1421531.8978734752
Depreciation & amortization: 2404146.3902406506
Net tangible assets: 47108059.46270249
Owner earnings: 383974.4017065526
Capex to operating income (%): 4164.03889923443
Buffett classification: The Gruesome
Stock price: 2.767415505632958
Shares outstanding: 10665550
Book value: 51620118.65875609
P/B ratio: 0.571792727584072
Market cap (USD): 29516008.446103595
Debt to equity: 0.26374094825437583
Current ratio: 2.3776522122207187
Quick ratio: 1.1514170647653743
Effective tax rate (%): 189.65511167476922
Interest coverage ratio: 0.3673888255416191
COGS to revenue (%): 70.36153345455247
R&D to revenue (%): 3.680475081433128
SG&A to revenue (%): 9.104361880287385
Free cash flow (dilution-adjusted): -4892960.469302047
Buyback yield (%): 0
Retained earnings: 17663389.10739284
Inventory turnover: 2.2536805126473833
Receivables turnover: 5.11304378773435
Capitalized R&D asset: 5268349.892630188
ROCI (R&D-adjusted, %): -0.31876041642371417
Rosenberg metric: -0.9304450637265824
FCF margin (%): -7.29853417387263
Revenue growth (%): -1.968386344216274
Rule of 40 score: -9.266920518088904
Financial ratios for 6897.T — quarterly report dated 2025-05-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.9952705522325775
Shares outstanding: 10665550
Market cap (USD): 31946207.83836417
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 6897.T — quarterly report dated 2026-02-28
Capital expenditures: 0
Net tangible assets: 39133344.02669062
Buffett classification: The Gruesome
Stock price: 2.701142050558193
Shares outstanding: 10665550
Book value: 42135191.83882972
P/B ratio: 0.6837316822367432
Market cap (USD): 28809165.597330935
Debt to equity: 0.324134321660509
Current ratio: 2.1865069513406157
Quick ratio: 0.9968187531032773
Buyback yield (%): 0
Retained earnings: 8274130.63005261
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 6897.T — annual report dated 2026-02-28
Total revenue: 57736847.17053766
Gross profit: 13691145.900166815
Operating income: -5487867.31682279
Net income: -7816617.477223149
Capital expenditures: 1801578.3395354804
Operating cash flow: 4737514.436032336
Depreciation & amortization: 2831772.103169511
Net tangible assets: 39133344.02669062
Owner earnings: -6786423.713589118
Return on net tangible assets (%): -17.34179350724662
Buffett classification: The Gruesome
Stock price: 2.701142050558193
Shares outstanding: 10665550
Book value: 42135191.83882972
P/B ratio: 0.6837316822367432
Market cap (USD): 28809165.597330935
Debt to equity: 0.324134321660509
Current ratio: 2.1865069513406157
Quick ratio: 0.9968187531032773
Interest coverage ratio: -29.876663523001152
COGS to revenue (%): 76.28698730339882
R&D to revenue (%): 4.059389711924782
SG&A to revenue (%): 9.784733963672085
Free cash flow (dilution-adjusted): 2935936.096496856
Buyback yield (%): 0
Retained earnings: 8274130.63005261
Inventory turnover: 2.2383892509784244
Receivables turnover: 7.536794665956443
Capitalized R&D asset: 4918174.185248007
ROCI (R&D-adjusted, %): -10.899401413474422
Rosenberg metric: -2.5040814932821154
FCF margin (%): 5.08503016769337
Revenue growth (%): -13.877425577088337
Rule of 40 score: -8.792395409394967
Financial ratios for 7004.T — annual report dated 2022-03-31
Total revenue: 3620693328.9624653
Gross profit: 591288313.3912474
Operating income: 127397148.0085232
Net income: 64841829.2083265
Capital expenditures: 58777249.631208
Operating cash flow: 220111457.1381741
Depreciation & amortization: 89501721.02933946
Net tangible assets: 982199639.4033766
Owner earnings: 95566300.60645795
Return on net tangible assets (%): 9.729824444296106
Capex to operating income (%): 46.13702155033773
Buffett classification: The Good
Stock price: 5.591788231437469
P/E ratio: 14.507760650104904
Shares outstanding: 168230573
Book value: 1089362399.6066222
P/B ratio: 0.8635415896574732
Market cap (USD): 940709738.2693821
Debt to equity: 0.6912220516987149
Current ratio: 1.2278259773543685
Quick ratio: 1.167018885364368
Effective tax rate (%): 33.35298576602375
Interest coverage ratio: 19.2150803461063
COGS to revenue (%): 83.66919648616899
R&D to revenue (%): 1.388873170256928
SG&A to revenue (%): 1.937541450032481
Free cash flow (dilution-adjusted): 144451729.22471726
Buyback yield (%): 0
Retained earnings: 583207670.8736273
Inventory turnover: 25.540523733849238
Receivables turnover: 2.328004215518377
Capitalized R&D asset: 50286838.2232421
ROCI (R&D-adjusted, %): 8.563980891071548
FCF margin (%): 3.989615139985106
Rule of 40 score: 3.989615139985106
Financial ratios for 7004.T — annual report dated 2023-03-31
Total revenue: 3698888888.8888893
Gross profit: 625810810.8108109
Operating income: 150608108.10810813
Net income: 117229729.72972974
Capital expenditures: 24707207.20720721
Operating cash flow: 210270270.2702703
Depreciation & amortization: 82379879.87987989
Net tangible assets: 964654654.6546547
Owner earnings: 174902402.40240243
Return on net tangible assets (%): 18.131089873299505
Capex to operating income (%): 16.404964857185583
Buffett classification: The Great
Stock price: 6.073573573573574
P/E ratio: 8.71588431360871
Shares outstanding: 168230573
Book value: 1060885885.8858862
P/B ratio: 0.9631203280518008
Market cap (USD): 1021760762.43994
Debt to equity: 0.6118816785790105
Current ratio: 1.3240798800719238
Quick ratio: 1.2527210135749614
Effective tax rate (%): 15.707654107740474
Interest coverage ratio: 25.45812182741117
COGS to revenue (%): 83.08111355573055
R&D to revenue (%): 1.7416560447500669
SG&A to revenue (%): 1.9896811801287617
Free cash flow (dilution-adjusted): 145397897.8978979
Buyback yield (%): 0
Retained earnings: 635773273.2732733
Inventory turnover: 23.820647113594042
Receivables turnover: 2.4836020123199147
Capitalized R&D asset: 98114103.53149414
ROCI (R&D-adjusted, %): 9.347046866478086
Rosenberg metric: 0.6865115930793908
FCF margin (%): 3.930853352601625
Revenue growth (%): 2.15968470184774
Rule of 40 score: 6.090538054449365